摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diisopropyl ethyl phosphonothiolformate | 163678-86-2

中文名称
——
中文别名
——
英文名称
diisopropyl ethyl phosphonothiolformate
英文别名
S-ethyl di(propan-2-yloxy)phosphorylmethanethioate
diisopropyl ethyl phosphonothiolformate化学式
CAS
163678-86-2
化学式
C9H19O4PS
mdl
——
分子量
254.287
InChiKey
AZKJBAUGYZCQSH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    301.7±25.0 °C(Predicted)
  • 密度:
    1.126±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    15
  • 可旋转键数:
    7
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    77.9
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    diisopropyl ethyl phosphonothiolformate盐酸羟胺 作用下, 以 吡啶 为溶剂, 反应 72.0h, 以54%的产率得到二异丙基亚磷酰胺
    参考文献:
    名称:
    Spontaneous Lossen Rearrangement of (Phosphonoformyl)hydroxamates. The Migratory Aptitude of the Phosphonyl Group
    摘要:
    (i-PrO)(2)P(=O)COSEt (1) reacted with NH2OH in pyridine at room temperature to give mainly (i-PrO)(2)P(=O)NH2 (4). The formation of 4 was interpreted in terms of a spontaneous Lessen rearrangement of (i-PrO)(2)P(=O)CONHOH (2a) formed in the reaction. A transient (PNMR)-P-31 signal appearing in the reaction mixture at delta -1.8 was assigned to 2a. Trapping of (i-PrO)(2)P(=O)N=C=O (5), formed in the reaction of 1 and NH2OH, by cyclohexylamine gave (i-PrO)(2)P(=O)NHCONHC6H11 (6). Attempted isolation of 6 gave the hydrolyzed product N-cyclohexylurea (7). The reaction of 1 with NH2OMe proceeded slower than that with NH2OH and gave the expected (i-PrO)(2)P(=O)CONHOMe (2b), which was isolated and identified. 2b converts slowly to 4 in pyridine at room temperature. In contrast, MeNHOH reacted rapidly with 1 and gave the stable crystalline (i-PrO)(2)P(=O)CON(Me)OH (2c). The structure of hydroxamates 2 were assigned on the basis of H-1, C-13, and P-31 NMR spectral data. This facile Lossen rearrangement is discussed in terms of the unusually high migratory aptitude of the phosphonyl group.
    DOI:
    10.1021/jo962075k
  • 作为产物:
    参考文献:
    名称:
    Salomon, Claudio J.; Breuer, Eli, Synlett, 2000, # 6, p. 815 - 816
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Compositions comprising oxophosphonate-based metalloproteinase inhibitors
    申请人:Yissum Research Development Company of the Hebrew University of Jerusalem
    公开号:US07101864B1
    公开(公告)日:2006-09-05
    The present invention relates to compositions useful for treating or controlling disease states or conditions associated with zinc containing proteinases, especially metalloproteinases. The active ingredient in these compositions is an alpha-oxo- or alpha-thixophosphpnate of formula (I). Out of the phosphonates of formula (I), some are known and others are new. The novel compounds constitute another aspect of the invention.
    本发明涉及用于治疗或控制与含锌蛋白酶,特别是金属蛋白酶相关的疾病状态或病况的组合物。这些组合物中的活性成分是具有化学式(I)的α-氧代或α-硫代膦酸酯。在化学式(I)的膦酸酯中,有些是已知的,而另一些是新的。这些新化合物构成了本发明的另一个方面。
  • [EN] CARJBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF<br/>[FR] CARBAMOYLPHOSPHONATES EN TANT QU'INHIBITEURS ET LEURS UTILISATIONS
    申请人:YISSUM RES DEV CO
    公开号:WO2010089752A1
    公开(公告)日:2010-08-12
    The present invention relates to novel metalloproteinase inhibitors having an aryloxybenzenesulfonamide moiety and a carbamoylphosphonic acid moiety, to pharmaceutical compositions comprising them, and to their uses in the prevention and/or treatment of disease or disorder associated with MMP.
    本发明涉及具有芳氧基苯磺酰胺基团和氨基甲酰磷酸基团的新型金属蛋白酶抑制剂,以及包含它们的药物组合物,以及它们在预防和/或治疗与MMP相关的疾病或紊乱中的用途。
  • CARBAMOYLPHOSPHONATES AS INHIBITORS AND USES THEREOF
    申请人:Breuer Eli
    公开号:US20120035140A1
    公开(公告)日:2012-02-09
    The present invention relates to novel metalloproteinase inhibitors having an aryloxybenzenesulfonamide moiety and a carbamoylphosphonic acid moiety, to pharmaceutical compositions comprising them, and to their uses in the prevention and/or treatment of disease or disorder associated with MMP.
    本发明涉及具有芳氧基苯磺酰胺基团和氨基甲酰磷酸基团的新型金属蛋白酶抑制剂,涉及包含它们的制药组合物,以及它们在预防和/或治疗与MMP相关的疾病或疾病中的应用。
  • Kovalenko, L. V.; Buvashkina, N. I.; Sosnov, A. V., Russian Journal of General Chemistry, 1994, vol. 64, # 10.1, p. 1456 - 1459
    作者:Kovalenko, L. V.、Buvashkina, N. I.、Sosnov, A. V.
    DOI:——
    日期:——
  • US8993544B2
    申请人:——
    公开号:US8993544B2
    公开(公告)日:2015-03-31
查看更多

同类化合物

(1-氨基丁基)磷酸 顺丙烯基磷酸 除草剂BUMINAFOS 阿仑膦酸 阻燃剂 FRC-1 铵甲基膦酸盐 钠甲基乙酰基膦酸酯 钆1,5,9-三氮杂环十二烷-N,N',N''-三(亚甲基膦酸) 钆-1,4,7-三氮杂环壬烷-N,N',N''-三(亚甲基膦酸) 重氮甲基膦酸二乙酯 辛基膦酸二丁酯 辛基膦酸 辛基-膦酸二钾盐 辛-1-烯-2-基膦酸 试剂12-Azidododecylphosphonicacid 英卡膦酸 苯胺,4-乙烯基-2-(1-甲基乙基)- 苯甲基膦酸二甲酯 苯基膦酸二甲酯 苯基膦酸二仲丁酯 苯基膦酸二乙酯 苯基膦酸二乙酯 苯基磷酸二辛酯 苯基二异辛基亚磷酸酯 苯基(1H-1,2,4-三唑-1-基)甲基膦酸二乙酯 苯丁酸,b-氨基-g-苯基- 苄基膦酸苄基乙酯 苄基亚甲基二膦酸 膦酸,[(2-乙基己基)亚氨基二(亚甲基)]二,triammonium盐(9CI) 膦酸叔丁酯乙酯 膦酸单十八烷基酯钾盐 膦酸二辛酯 膦酸二(二十一烷基)酯 膦酸,辛基-,单乙基酯 膦酸,甲基-,单(2-乙基己基)酯 膦酸,甲基-,二(苯基甲基)酯 膦酸,甲基-,2-甲氧基乙基1-甲基乙基酯 膦酸,丁基乙基酯 膦酸,[苯基[(苯基甲基)氨基]甲基]-,二甲基酯 膦酸,[[羟基(苯基甲基)氨基]苯基甲基]-,二(苯基甲基)酯 膦酸,[2-(环丙基氨基)-2-羰基乙基]-,二乙基酯 膦酸,[2-(二甲基亚肼基)丙基]-,二乙基酯,(E)- 膦酸,[1-甲基-2-(苯亚氨基)乙烯基]-,二乙基酯 膦酸,[1-(乙酰基氨基)-1-甲基乙基]-(9CI) 膦酸,[(环己基氨基)苯基甲基]-,二乙基酯 膦酸,[(二乙氧基硫膦基)(二甲氨基)甲基]- 膦酸,[(2S)-2-氨基-2-苯基乙基]-,二乙基酯 膦酸,[(1Z)-2-氨基-2-(2-噻嗯基)乙烯基]-,二乙基酯 膦酸,P-[(二乙胺基)羰基]-,二乙基酯 膦酸,(氨基二环丙基甲基)-